中文名称: | BAY-707 | ||||
---|---|---|---|---|---|
英文名称: | BAY-707 | ||||
CAS No: | 2109805-96-9 | 分子式: | C15H20N4O2 | 分子量: | 288.34 |
CAS No: | 2109805-96-9 | ||||
分子式: | C15H20N4O2 | ||||
分子量: | 288.34 |
基本信息
产品编号:B10783 |
|||||
产品名称:BAY-707 |
|||||
CAS: |
2109805-96-9 |
储存条件 |
粉末 |
-20℃ |
四年 |
分子式: |
|||||
分子量 |
288.34 |
||||
化学名: |
1H-?Pyrrolo[2,?3-?b]?pyridine-?2-?carboxamide, N-?ethyl-?4-?[(3S)?-?3-?methyl-?4-?morpholinyl]?- |
||||
Solubility (25°C) |
体外 |
DMSO |
|
||
Ethanol |
|
||||
Water |
|
||||
体内 |
现配现用 |
|
|||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
生物活性
产品描述 |
一种MTH1(NUDT1) 的底物竞争性,高效选择性抑制剂,IC50 值 为 2.3nM。 |
靶点/IC50 |
MTH1/NUDT1 IC50:2.3nM |
体外研究 |
BAY-707 demonstrates a superior cellular target engagement with an EC50 of 7.6nM, in agreement with its higher enzymatic potency (IC50=2.3nM). BAY-707 demonstrates a high cell permeability cell permeability in the Caco-2 assay with a efflux ratio of 288nm/s. BAY-707 shows an overall favorable physicochemical profile and promising in vitro pharmacokinetic properties with high metabolic stability in both human microsomes(0.29L/h/kg,Fmax=78%) and rat hepatocytes (0.54L/h/kg,Fmax=87%) . BAY-707 (0-30μM; 24 hours) has no antiproliferative effects in HMEC, HeLa and SW-480 cells. |
体内研究 |
Bay-077 (orally adminstation; 50-250mg/kg; 2 weeks) exhibits superior biochemical potency, cellular target engagement, and a pharmacokinetic profile to other MTH1 tool compounds, But Bay-077 exerts no anticancer efficacy either in mono- or in combination therapies in CT26 and NCI-H460 mice model. BAY-707 (orally adminstation; 50-250mg/kg; 2 weeks) is well-tolerated in nude mice, after 7-days treatment, body weight loss does not exceed 10% . |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )